Skip to main content

Pharvaris N.V.

PHVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001830487

In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.

Q4 2023 vs. Q3 2023

How the institutions holding Pharvaris N.V. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of PHVS: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders2136+15
Shares29.1M40.7M+11.7M (+40.2%)
Value$606.6M$1.14B+$536.3M (+88.4%)

New holders (18)

Institutions that held Pharvaris N.V. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to PHVS in Q4 2023
InstitutionSharesValue% of portfolio
EcoR1 Capital, LLC900,000$25.2M0.66%
Price T Rowe Associates Inc842,698$23.6M0.00%
Deerfield Management Company, L.P. (Series C)812,236$22.8M0.42%
Commodore Capital LP800,000$22.4M1.96%
Sofinnova Investments, Inc.510,441$14.3M0.80%
Vivo Capital, LLC285,000$7.99M0.65%
Sphera Funds Management Ltd.245,000$6.87M1.28%
Millennium Management LLC188,516$5.29M0.01%
Citadel Advisors LLC141,458$3.97M0.00%
Blackstone Group Inc.100,000$2.81M0.01%
Marshall Wace, LLP60,124$1.69M0.00%
Manufacturers Life Insurance Company, The55,078$1.54M0.00%
UBS Oconnor LLC18,000$504.9K0.02%
Goldman Sachs Group Inc8,549$239.8K0.00%
Two Sigma Investments, LP8,198$230.0K0.00%
Quarry LP750$21.0K0.01%
JPMorgan Chase & Co190$5.33K0.00%
Piper Sandler & Co.181$5.08K0.00%

Sold out (3)

Institutions that held Pharvaris N.V. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of PHVS in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Foresite Capital Management V, LLC33,142$691.7K
Y-Intercept (Hong Kong) Ltd17,553$366.3K
UBS Group AG50$1.04K